M&A Deal Summary

EQT and Aztiq Acquire Adalvo

On July 18, 2025, private equity firms EQT and Aztiq acquired life science company Adalvo from Aztiq

Acquisition Highlights
  • This is EQT’s 15th and Aztiq’s 4th transaction in the Life Science sector.
  • This is EQT’s 2nd and Aztiq’s 1st transaction in Malta.

M&A Deal Summary

Date 2025-07-18
Target Adalvo
Sector Life Science
Buyer(s) EQT
Aztiq
Sellers(s) Aztiq
Deal Type Secondary Buyout

Target

Adalvo

San Gwann, Malta
Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 140 countries and over 170+ commercial partners globally. Adalvo is based in San Gwann, Malta.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 2

Buyer

EQT

Stockholm, Sweden

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1994
PE ASSETS 242.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

EQT is a global private equity group that purses a variety of investment strategies around the world. EQT is divided into several investment disciplines, including private capital, real assets, credit, and venture. The Firm's private capital group targets large, market-leading enterprises (investment size of €125 to €1.5 billion) across Europe and the US, as well as mid-market, growth companies (investment size of €40 to €125 million) across the US, Europe, China, and Southeast Asia. The Firm's real assets group seeks to identify control or co-control equity investments (investment size of €500 to €1 billion) in medium-sized infrastructure companies that provide an essential service to society, are recession resilient, and have secure cash flows. EQT's credit group provides flexible, long-term debt capital solutions to medium-sized European businesses, across a wide range of sectors. EQT was established in 1994 and is headquartered in Stockholm, Sweden.


DEAL STATS #
Overall 313 of 318
Sector: Life Science M&A 15 of 15
Type: Secondary Buyout M&A Deals 99 of 101
Country: Malta M&A 2 of 2
Year: 2025 M&A 6 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-03 Europa Biosite

Täby, Sweden

Europa Biosite is an European distributor of life science products, dedicated to raising the standards of life science distribution. Europa Biosite is based in Täby, Sweden.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-21 Adevinta - Spanish Online Classifieds Businesses

Madrid, Spain

Adevinta's Spanish Online Classifieds Businesses comprise a portfolio of digital marketplaces that operate across key verticals, including automotive, employment, real estate, and general classifieds. Adevinta's Spanish online classifieds businesses are based in Madrid, Spain.

Buy -
Buyer

Aztiq

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2009
PE ASSETS 1.5B USD
Size Large
Type Sector Focused
DESCRIPTION

Aztiq is a specialist investment firm focused on the life science sector and seeks to partner with companies throughout Europe. Aztiq was formed in 2009 and is based in Reykjavik, Iceland.


DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Secondary Buyout M&A Deals 1 of 1
Country: Malta M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-26 Lotus

Taipei, Taiwan

Lotus is an international pharmaceutical company with a global presence, focused on commercializing both novel and generic pharmaceuticals to provide patients with better, safer, and more accessible medicines. Lotus was founded in 1966 and is based in Taipei, Taiwan.

Buy -

Seller(S) 1

SELLER

Aztiq

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2009
PE ASSETS 1.5B USD
Size Large
Type Sector Focused
DESCRIPTION

Aztiq is a specialist investment firm focused on the life science sector and seeks to partner with companies throughout Europe. Aztiq was formed in 2009 and is based in Reykjavik, Iceland.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Secondary Buyout M&A Deals 1 of 1
Country: Malta M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-26 Lotus

Taipei, Taiwan

Lotus is an international pharmaceutical company with a global presence, focused on commercializing both novel and generic pharmaceuticals to provide patients with better, safer, and more accessible medicines. Lotus was founded in 1966 and is based in Taipei, Taiwan.

Buy -